Literature DB >> 1538215

Frequency of central lesions in polyneuropathy associated with IgM monoclonal gammopathy: an MRI, neurophysiological and immunochemical study.

J M Léger1, A B Younes-Chennoufi, M Zuber, P Bouche, M O Jauberteau, D Dormont, F Danon, N Baumann, P Brunet.   

Abstract

CNS lesions were studied in polyneuropathy associated with IgM monoclonal gammopathy. Eleven out of 12 patients with IgM MGUS and one patient with Waldenstrom's disease had clinical and electrophysiological features indicating a demyelinating polyneuropathy. MRI showed CNS white matter lesions in two cases. Antibodies reacting against glycolipids present in CNS white matter were present in five cases, two of which had abnormal MRI. Central conduction times cortex-C7, obtained by magnetic stimulation, were prolonged in 3/8 patients, of which two patients had anti-CNS glycolipid antibodies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1538215      PMCID: PMC488972          DOI: 10.1136/jnnp.55.2.112

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  20 in total

1.  SEPARATION OF CARBOHYDRATES ON BORATE-IMPREGNATED SILICA GEL G PLATES.

Authors:  H JACIN; A R MISHKIN
Journal:  J Chromatogr       Date:  1965-04

2.  Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.

Authors:  L SVENNERHOLM
Journal:  Biochim Biophys Acta       Date:  1957-06

3.  Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy and in neuropathy associated with IgM monoclonal gammopathy of unknown significance.

Authors:  P J Dyck
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

4.  Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: a clinical, electrophysiological and magnetic resonance imaging study.

Authors:  I E Ormerod; H M Waddy; A G Kermode; N M Murray; P K Thomas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-09       Impact factor: 10.154

5.  Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis.

Authors:  F Fazekas; H Offenbacher; S Fuchs; R Schmidt; K Niederkorn; S Horner; H Lechner
Journal:  Neurology       Date:  1988-12       Impact factor: 9.910

6.  Cranial magnetic resonance imaging in chronic demyelinating polyneuropathy.

Authors:  S H Hawke; J M Hallinan; J G McLeod
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-09       Impact factor: 10.154

7.  The electrodiagnostic findings in polyneuropathies associated with IgM monoclonal gammopathies.

Authors:  J J Kelly
Journal:  Muscle Nerve       Date:  1990-12       Impact factor: 3.217

8.  Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  J R Mendell; S Kolkin; J T Kissel; K L Weiss; D W Chakeres; K W Rammohan
Journal:  Neurology       Date:  1987-08       Impact factor: 9.910

9.  Monoclonal IgM kappa antibody precipitating with chondroitin sulfate C from patients with axonal polyneuropathy and epidermolysis.

Authors:  W H Sherman; N Latov; A P Hays; M Takatsu; R Nemni; G Galassi; E F Osserman
Journal:  Neurology       Date:  1983-02       Impact factor: 9.910

10.  Chronic demyelinating neuropathy associated with benign IgM paraproteinaemia.

Authors:  I S Smith; S N Kahn; B W Lacey; R H King; R A Eames; D J Whybrew; P K Thomas
Journal:  Brain       Date:  1983-03       Impact factor: 13.501

View more
  2 in total

Review 1.  Neuropathy associated with "benign" anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases.

Authors:  E Ellie; A Vital; A Steck; J M Boiron; C Vital; J Julien
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

2.  Therapeutic experience of Bing-Neel Syndrome associated with Waldenstrom's macroglobulinemia.

Authors:  Hyun Do Kim; Kyeong Cheol Shin; Hee Soon Cho; Min Kyoung Kim; Kyung Hee Lee; Myung Soo Hyun
Journal:  J Korean Med Sci       Date:  2007-12       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.